eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
暂无分享,去创建一个
N. Sonenberg | T. Alain | A. Yanagiya | M. Bhat | P. Metrakos | I. Topisirovic | B. Fonseca | V. Gandin | N. Siddiqui | M. Morita | V. Marcus | Domenick Zammit | Yi Liu | Lucie-Anne Voyer | Akiko Yanagiya
[1] N. Sonenberg,et al. Translational homeostasis via the mRNA cap-binding protein, eIF4E. , 2012, Molecular cell.
[2] Nicholas T. Ingolia,et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.
[3] Gordon B Mills,et al. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. , 2012, Cancer cell.
[4] M. Hall,et al. Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.
[5] N. Ilić,et al. PI3K-targeted therapy can be evaded by gene amplification along the MYC-eukaryotic translation initiation factor 4E (eIF4E) axis , 2011, Proceedings of the National Academy of Sciences.
[6] E. Jacinto,et al. mTOR complex 2 signaling and functions , 2011, Cell cycle.
[7] A. Zask,et al. Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent review , 2011, Expert opinion on therapeutic patents.
[8] J. Blenis,et al. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. , 2011, Trends in biochemical sciences.
[9] E. D. de Vries,et al. Everolimus for advanced pancreatic neuroendocrine tumors. , 2011, The New England journal of medicine.
[10] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[11] Q. She,et al. 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. , 2010, Cancer cell.
[12] N. Sonenberg,et al. mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs , 2010, Science.
[13] R. Jackson,et al. The mechanism of eukaryotic translation initiation and principles of its regulation , 2010, Nature Reviews Molecular Cell Biology.
[14] B. Pulendran,et al. Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production , 2010, Proceedings of the National Academy of Sciences.
[15] C. Chresta,et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) , 2009, The Biochemical journal.
[16] D. Guertin,et al. The Pharmacology of mTOR Inhibition , 2009, Science Signaling.
[17] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[18] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[19] Robbie Loewith,et al. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.
[20] T. Hoang,et al. Stability of Eukaryotic Translation Initiation Factor 4E mRNA Is Regulated by HuR, and This Activity Is Dysregulated in Cancer , 2008, Molecular and Cellular Biology.
[21] B. Manning,et al. Common corruption of the mTOR signaling network in human tumors , 2008, Oncogene.
[22] A. Gingras,et al. Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. , 2008, RNA.
[23] H. Aburatani,et al. ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress. , 2008, Cell metabolism.
[24] J. Graff,et al. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. , 2008, Cancer research.
[25] N. Sonenberg,et al. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. , 2007, Cancer research.
[26] Tao Wang,et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. , 2007, The Journal of clinical investigation.
[27] N. Sonenberg,et al. Epigenetic Activation of a Subset of mRNAs by eIF4E Explains Its Effects on Cell Proliferation , 2007, PloS one.
[28] J. Baselga,et al. 4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis , 2007, Clinical Cancer Research.
[29] Johan Auwerx,et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.
[30] N. Sonenberg,et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. , 2004, Cancer cell.
[31] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[32] C. Meschonat,et al. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor. , 1999, The Journal of surgical research.
[33] S. Gygi,et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.
[34] A. Gingras,et al. 4E-BP3, a New Member of the Eukaryotic Initiation Factor 4E-binding Protein Family* , 1998, The Journal of Biological Chemistry.
[35] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[36] A. Gingras,et al. Structure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein , 1997, Nature Structural Biology.
[37] Christine C. Hudson,et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.
[38] A. Gingras,et al. Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP , 1997, Cell.
[39] A. Gingras,et al. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. , 1996, Oncogene.
[40] M. Polymenis,et al. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc , 1996, Molecular and cellular biology.
[41] N. Sonenberg,et al. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins , 1995, Molecular and cellular biology.
[42] A. Gingras,et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.
[43] N. Sonenberg,et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.
[44] J. Stockman,et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors , 2012 .
[45] A. Rich,et al. A multiple ribosomal structure in protein synthesis. , 1963, Proceedings of the National Academy of Sciences of the United States of America.